INTRODUCTION The deepening process of demographic aging has a significant impact on all areas of the society. With increasing age, the presence of illness, as well as the amount of used drugs increases. The most commonly prescribed drugs are often proton pump inhibitors, which play an irreplaceable role in the treatment of many gastrointestinal diseases. The trend of the overuse of proton pump inhibitors as the main antisecretory drugs is mainly related to their long-term administration in the prophylaxis of concurrent use of gastrotoxic drugs. The aim of this work was to evaluate the rationality of use of proton pump inhibitors including indications, administered dosages and duration of treatment. METHODS The data collected and used in this work are a part of the FIP7 project of the EUROAGEISM H2020 program. The study involved 438 geriatric patients in acute care institutions in Brno, Prague, and Hradec Králové, who were hospitalized between August 2018 and January 2019. The inclusion criteria were age over 65 years and adherence to inclusion criteria of the study. Seniors with severe cognitive impairment (MMSE < 10 points), memory impairment, speech or hearing impairment, patients hospitalized in the intensive care unit and in the terminal stage of the disease were excluded from the study. Data...
| Identifer | oai:union.ndltd.org:nusl.cz/oai:invenio.nusl.cz:408145 |
| Date | January 2019 |
| Creators | Masaryková, Petra |
| Contributors | Fialová, Daniela, Doseděl, Martin |
| Source Sets | Czech ETDs |
| Language | Slovak |
| Detected Language | English |
| Type | info:eu-repo/semantics/masterThesis |
| Rights | info:eu-repo/semantics/restrictedAccess |
Page generated in 0.002 seconds